Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with (177)Lu-DOTATATE

Peptide receptor radiotherapy (PRRT) with (177)Lu-DOTATATE has emerged as a promising therapy for neuroendocrine tumors (NETs). This retrospective cohort study aimed to assess the outcome of PRRT for 22 patients with histopathologically confirmed pheochromocytoma (PCC) and paraganglioma (PGL), of wh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Vyakaranam, Achyut Ram, Crona, Joakim, Norlén, Olov, Granberg, Dan, Garske-Román, Ulrike, Sandström, Mattias, Fröss-Baron, Katarzyna, Thiis-Evensen, Espen, Hellman, Per, Sundin, Anders
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6678507/
https://ncbi.nlm.nih.gov/pubmed/31261748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11070909
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller